Company

Boston Scientific


Bos Sci’s Q2 takes hit from defib sales halt; stent sales drop too

Financial News | Wednesday, July 21 2010
Boston Scientific has filed financial results for its second quarter, ending June 30, which were adversely affected by the FDA's halt on defibrillator systems, along with falling stent sales.
 

Bos Sci merges IVUS with Philips, Siemens technology

Partnerships & Alliances | Monday, May 24 2010
A partnership between Boston Scientific, Philips Healthcare and Siemens Healthcare will enable Boston Scientific’s iLab intravascular ultrasound (IVUS) imaging system to be used in conjunction with Philips’ Allura Xper and Siemens' Axiom Artis and Artis zee interventional x-ray systems.
 

Former Bos Sci exec fills new clinical development role at Lantheus

Executive Announcements | Thursday, April 22 2010
Lantheus Medical Imaging has appointed Dana S. Washburn, MD, to the newly created position of vice president, clinical development and medical affairs.
 

Bos Sci settles long-standing stent patent disputes with J&J for $1.7B

Top Stories | Thursday, February 04 2010
Boston Scientific has settled three patent disputes with Johnson & Johnson (J&J) for $1.73 billion.
 

Boston Scientific unveils iLab upgrade

New Products | Monday, September 21 2009
Boston Scientific has released an upgrade to its iLab software for the iLab ultrasound imaging system--intravascular ultrasound technology that provides a 360-degree view inside the heart and coronary vessels.
 

Radiologist continues stent infringement suits, sets sights on Abbott

Top Stories | Thursday, August 27 2009
New Jersey radiologist Bruce N. Saffran, MD, who was awarded about $500 million in a 2008 patent infringement case against Boston Scientific, filed suit Monday in the U.S. District Court for the Eastern District of Texas over Abbott's Xience V everolimus-eluting coronary stent.
 

Cook, Angiotech peripheral DES gains CE Mark

Regulatory News | Tuesday, August 11 2009
Cook Medical and Angiotech Pharmaceuticals received CE Mark approval Monday for their polymer-free Zilver PTX drug-eluting peripheral stent to treat blockages in the legs caused by peripheral arterial disease.
 

Boston Sci sees Q2 income uptick on strong stent, CRM sales

Financial News | Tuesday, August 04 2009
Boston Scientific has reported positive financial earnings for its fiscal 2009 second quarter, which ended June 30. The Natick, Mass.-based medical device company booked a net income of $158 million this quarter, compared with $98 million in the second quarter of 2008.
 

Medtronic settles stent patent suit with Abbott to the tune of $400M

Top Stories | Monday, July 27 2009
Abbott today settled all outstanding intellectual property litigation with Medtronic. Under the terms of the settlement, Medtronic will pay Abbott $400 million and $42 million to evYsio Medical Devices, based in Vancouver, British Columbia.


 

FDA clears 38-mm DES from Boston Scientific

Regulatory News | Friday, July 17 2009
Boston Scientific has received FDA approval to market its Taxus Liberte Long paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) designed for long lesions.
 

Boston Scientific switches CEOs, with a look away from cardiac devices

Top Stories | Friday, June 26 2009
Boston Scientific has announced that President and CEO Jim Tobin will retire and that its board of directors has appointed Ray Elliott the new president and CEO, effective July 13.
 

FDA clears Boston Scientific endoscopic catheter

Regulatory News | Friday, May 29 2009
Boston Scientific has received 510(k) clearance from the FDA to market its SpyScope Access and Delivery catheter for diagnostic and therapeutic applications during endoscopic procedures of the pancreatico-biliary system.
 

FDA clears Bos Sci stent for 2.25mm heart vessels

Regulatory News | Wednesday, May 27 2009
Boston Scientific has received approval from the FDA to market its Taxus Liberte Atom paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) designed for treating small coronary vessels, as small as 2.25 mm in diameter.
 

Boston Scientific launches coronary imaging catheter

New Products | Friday, March 20 2009
Boston Scientific has launched its iCross coronary imaging catheter, a product designed to improve the deliverability of its intravascular ultrasound system, iLab.
 

3D CT delivers thoracoscopic surgery guidance

Portal Exclusives | Tuesday, November 30 1999
The use of CT advanced visualization software enables the safe and effective placement of fiber-coated microcoils used to guide video-assisted thoracoscopic surgical (VATS) excision of small peripheral lung nodules, according to a study published in this month’s issue of Radiology.
 

Boston Scientific net loss widens in Q4, despite improved U.S. stent sales

Financial News | Thursday, January 29 2009
Boston Scientific has reported its financial results for the 2008 fourth fiscal quarter and full year, which ended Dec. 31, 2008.
 

Dust settles on Bos Sci, Medtronic interventional litigations

Industry News | Thursday, January 29 2009
Boston Scientific and Medtronic have settled two lawsuits and signed an agreement to stand down in three others, which will stop all current litigation between the two companies in the fields of interventional cardiology and endovascular repair.
 

Stent vs. Graft: Choosing the Best Path for the Diabetic Patient with Multivessel Disease

Features | Friday, January 09 2009
The prevailing notion is that bypass surgery is superior to stenting in patients with diabetes. The truth, however, is more complicated, as the decision-makers learn to examine the individual pathologies in lieu of standardization. Often, this process is more art than science in taking into account all of the parameters of a patient’s disease.
 

Advanced viz aids coronary stent fracture detection

Clinical Studies | Wednesday, December 10 2008
 
The use of advanced visualization software enables the utilization of coronary CT angiography (CCTA) to accurately depict stent fractures in patients that are not clearly depicted by conventional angiography, according to a study published in the December issue of Radiology.
 

Boston Scientific's Apex PTCA dilatation catheter receives FDA approval

Regulatory News | Monday, November 10 2008
Boston Scientific reported that it has received approval from the U.S. Food and Drug Administration to market its Apex percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics